EAST.V - EastWest Bioscience Inc.

TSXV - TSXV Delayed Price. Currency in CAD
0.0400
+0.0050 (+14.29%)
At close: 3:36PM EST
Stock chart is not supported by your current browser
Previous Close0.0350
Open0.0400
Bid0.0350 x 0
Ask0.0400 x 0
Day's Range0.0400 - 0.0400
52 Week Range0.0200 - 0.2100
Volume42,000
Avg. Volume221,272
Market Cap3.262M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0570
Earnings DateNov 20, 2019 - Nov 23, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    InnerScope Hearing Technologies Inc. (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE INC. (TSX.V: EAST)

    EASTWEST BIOSCIENCE INC. and InnerScope Hearing Technologies Inc. have entered into an Agreement for both companies to establish distribution and marketing rights to include warehousing and distribution ...

  • GlobeNewswire

    InnerScope Hearing Technologies (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE (TSX.V: EAST)  

    ROSEVILLE, Calif. and VANCOUVER, B.C., Nov. 06, 2019 -- via OTC PR WIRE -- InnerScope Hearing Technologies Inc. (OTCQB: INND) ("InnerScope") a manufacturer and.

  • Could The EastWest Bioscience Inc. (CVE:EAST) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The EastWest Bioscience Inc. (CVE:EAST) Ownership Structure Tell Us Something Useful?

    A look at the shareholders of EastWest Bioscience Inc. (CVE:EAST) can tell us which group is most powerful...

  • ACCESSWIRE

    EastWest Bioscience Continues Expansion in US with Its First Production Run of CBD Pet Products

    LEBANON, KN / ACCESSWIRE / October 30, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on July 23rd, the Company has completed the first production run of its CBD Pet Treats for the US Market. The premium CBD used in these CBD pet treats was supplied and produced through its joint venture partnership with Azema Sciences at its facility in Lebanon, Kentucky, USA.

  • CNW Group

    IIROC Trading Resumption - EAST

    IIROC Trading Resumption - EAST

  • CNW Group

    IIROC Trading Halt - EAST

    IIROC Trading Halt - EAST

  • ACCESSWIRE

    EastWest Bioscience Signs Distribution and Broker Deal with Rise North America Based in the United States

    VANCOUVER, BC / ACCESSWIRE / September 10, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) announces that it has signed a distribution and broker agreement with RISE North America (“RISE NA”) headquartered in Annapolis, MD. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium health and hemp products.

  • Easy Come, Easy Go: How EastWest Bioscience (CVE:EAST) Shareholders Got Unlucky And Saw 70% Of Their Cash Evaporate
    Simply Wall St.

    Easy Come, Easy Go: How EastWest Bioscience (CVE:EAST) Shareholders Got Unlucky And Saw 70% Of Their Cash Evaporate

    It's not a secret that every investor will make bad investments, from time to time. But it should be a priority to...

  • ACCESSWIRE

    EastWest Bioscience to Enter the People's Republic of China with Its Full Line of Hemp-Based Products

    VANCOUVER, BC / ACCESSWIRE / August 15, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) announces that it is in the final stages of obtaining it’s Business License to sell products into the People’s Republic of China through a strategic new partnership with Diverse Global Service (DGS), based in Chengdu Area of China (Sichuan) Pilot Free Trade Zone, who are both EastWest’s consultants and brokers. Chengdu has a diverse economy highlighting the food industry, IT and automotive manufacturing. It is one of the most important economic centers in Western China.

  • ACCESSWIRE

    EastWest Bioscience Signs Letter of Intent with Pet Tonics.

    VANCOUVER, BC / ACCESSWIRE / August 1, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) has signed an LOI with Pet Tonics, LLC, DBA Paws Effect (“Paws”), located in Coppell, TX USA (pawseffect.com). Partnering with strong brands is a significant part of EastWest’s overall strategy to ensure a larger footprint in the retail landscape in Canada, the USA, and Asia. Pet Tonics’ current products include CBD biscuits, balms, and tinctures.

  • ACCESSWIRE

    EastWest Bioscience Announces Grant of Stock Options

    VANCOUVER, BC / ACCESSWIRE / July 24, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) announces that it has granted stock options (“Options”) to acquire up to 3,792,500 common shares of the Company, 1,125,000 of which were granted to directors and officers of the Company. Each of the Options vested immediately, are exercisable for a five-year term, expiring in 2024 and exercisable at a price of $0.15 per common share. On the last day that the Company's common shares traded prior to the granting of the Options, the closing price of the common shares on the TSX Venture Exchange was $0.08 per share.

  • ACCESSWIRE

    EastWest USA Received First Batch of Full Spectrum CBD Oil from Azema Sciences for CBD Pet Treats

    VANCOUVER, BC / ACCESSWIRE / July 23, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) announces that, further to its News Releases on April 26th and June 25th, 2019, that the Company has received the first batch of its Full Spectrum CBD Oil for its initial pet orders for the US Market from its preferred supply and distribution Joint Venture with Azema Sciences out of its facility in Lebanon, Kentucky. Initially, the +CBD Chill Dog and +CBD Quick Cat will be sold through the company’s Kentucky based distribution arm, EastWest Science USA. “The Company continues to move forward at a rapid pace.

  • How Financially Strong Is EastWest Bioscience Inc. (CVE:EAST)?
    Simply Wall St.

    How Financially Strong Is EastWest Bioscience Inc. (CVE:EAST)?

    While small-cap stocks, such as EastWest Bioscience Inc. (CVE:EAST) with its market cap of CA$6.1m, are popular for...

  • ACCESSWIRE

    EastWest Bioscience Reports Third Quarter 2019 Financial Results

    VANCOUVER, BC / ACCESSWIRE / July 4, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) expands on its vision, strategy, and outlook for the future and comments on its 3Q financial results for the three months ended April 30, 2019. "US Approval was a tremendous achievement this quarter," explains Rodney Gelineau, CEO of EastWest Bioscience. Eastwest concluded its Joint Venture agreement with Azema Sciences, allowing it to start the production of CBD from its Kentucky facility, for its line of consumer products.

  • ACCESSWIRE

    EastWest Science USA Signs Mutual US Distribution Agreement with CBD Manufacturer GM Health Wholesale

    VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that its subsidiary EastWest Science USA has signed a mutual distributor agreement with GM Health Wholesale ("GM Health") (www.gmhempco.com), a Kentucky company and a leading manufacturer and wholesaler of CBD Tinctures, Creams, Salves and Capsules. Under the terms of this agreement GM Health will become a distributor of EastWest's products and EastWest will become a global distributor for GM Health's all-natural CBD products.

  • ACCESSWIRE

    EastWest Bioscience Starts Production of CBD Pet Treats for the US Market

    VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on April 26th, 2019, that the Company has started production of CBD infused Chill Dog and Quick Cat for the US Market. +CBD Chill Dog and +CBD Quick Cat will be sold through the company's Kentucky based distribution arm, EastWest Science USA. EastWest is working with distributors in the US for product launch pre-orders.

  • ACCESSWIRE

    EastWest Bioscience Continues Expansion in Western Canada Through Avafina Pet Products

    VANCOUVER, BC / ACCESSWIRE / June 24, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that it has partnered with Avafina Pet Products ("Avafina") (www.avafinapet.com) to distribute its Natural Pet Science line of pet treats into more than 300 stores across Western Canada. Avafina's passionate and knowledgeable sales professionals, along with their distribution centre in Coquitlam, BC, provides a strategic distribution and sales partnership into the independent and retail chain channel for EastWest. Avafina's customer base includes strong independent pet food retailers along with some of the largest growing pet chains in Canada.

  • ACCESSWIRE

    EastWest Bioscience Signs Definitive Joint Venture Agreement with Azema Sciences; US Expansion Story Continues

    VANCOUVER, BC / ACCESSWIRE / June 20, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on April 30th, 2019 that the Company has signed a Definitive Agreement with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement, specifically for the supply of bulk CBD and finished CBD products, and distribution throughout the US and Globally. EastWest is entering into a Joint Venture with Azema, securing for EastWest first rights on Azema's output of bulk CBD and finished CBD products which are ready for sale in the USA and globally.

  • ACCESSWIRE

    DTC Application Update: EastWest Bioscience Passes Due Diligence for FINRA Form 15c-211

    VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on May 7th 2019, it has passed third party due diligence pursuant to FINRA Rule 15c2‐11 ("Form 211"), as part of the Company's DTC application. Form 211 clearance is important as it requires the Directors and Principals of EAST, in addition to the Company itself to pass the regulatory background checks and due diligence necessary to list in the U.S. Form 211 clearance opens the way for EAST to complete the DTC's due diligence and subsequently finalize the Company's application for listing on the OTC Markets QB Exchange.

  • ACCESSWIRE

    EastWest Bioscience Continues Global Expansion Through a Distribution Agreement with New Zealand Hemp Brokers

    VANCOUVER, BC / ACCESSWIRE / June 18, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (EAST.V) announces that it has signed a distributor agreement with New Zealand Hemp Brokers (NZHB) (www.nzhempbrokers.com), a leading wholesaler and New Zealand's only specialist Hemp Broker with reach into important key markets in New Zealand, Australia, and Asia. NZHB are experts in the distribution, import and export of industrial hemp (iHemp) and hemp products. EastWest will begin shipping Earth's Menu, Natural Pet Science, Chanvre Hemp and Natural Advancement products within the next 2 months with plans to ship CBD products, currently in various stages of formulation and manufacturing, from the United States.

  • ACCESSWIRE

    EastWest Bioscience Receives TSX Approval for Operations in 20 Additional US States.

    VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands into 20 Additional US States with TSX approval. On June 6th, 2019, ...

  • ACCESSWIRE

    EastWest Bioscience signs Letter of Intent with Benchmark Botanics

    VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that it has signed a Letter of Intent for a J oint V enture with Benchmark Botanics Inc. ("Benchmark") (CSE:BBT) for the purposes of Cannabis Act licensing, joint product development, and product distribution to national and international markets. EastWest and Benchmark are excited to be aligning their Canadian businesses across multiple stages of the product lifecycle. Benchmark Botanics' 100% owned subsidiary, Potanicals Green Growers Inc. is a Health Canada licensed producer under the Cannabis Act , located in Peachland, BC, a 45- minute drive from the facility owned and operated by EastWest in Penticton, BC. Benchmark also continues with their greenhouse construction in Pitt Meadows, BC.

  • ACCESSWIRE

    EastWest Bioscience Signs Letter of Intent to Joint Venture with Continental Agro Trade Corporation a Canadian Industrial Hemp Grower

    VANCOUVER, BC / ACCESSWIRE / May 15, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces that on May 13, 2019 they signed a Letter of Intent to joint venture ...

  • ACCESSWIRE

    EastWest Bioscience Contracts Internal Investor Relations Representative

    VANCOUVER, BC / ACCESSWIRE / May 14, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) advises that on February 1, 2019 the Company contracted Mr. Nicholas Vincent, ...

  • ACCESSWIRE

    EastWest Bioscience Inc. Announces Submission of DTC and OTCQB Venture Market Applications

    VANCOUVER, BC / ACCESSWIRE / May 7, 2019 / EastWest BioScience Inc. ("Company" or "EastWest") (TSXV: EAST) announces its eligibility to The Depository Trust Company ("DTC") ...